Análisis preliminares de la versión adaptada en población chilena de la escala de adherencia terapéutica en diabetes mellitus tipo 2 - EATDM-III
Author
dc.contributor.author
Urzúa M., Alfonso
Author
dc.contributor.author
Cabrera R., Carlos
Author
dc.contributor.author
González V., Christofer
Author
dc.contributor.author
Arenas R., Pablo
Author
dc.contributor.author
Guzmán G., Mónica
Author
dc.contributor.author
Caqueo Urízar, Alejandra
Author
dc.contributor.author
Villalobos P., Alfonso
Author
dc.contributor.author
Irarrázaval Domínguez, Matías
Admission date
dc.date.accessioned
2015-10-19T18:53:47Z
Available date
dc.date.available
2015-10-19T18:53:47Z
Publication date
dc.date.issued
2015
Identifier
dc.identifier.issn
0034-9887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/134471
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Background: The Diabetes Mellitus 2 treatment adherence scale version III
(EATDM-III) was devised in Costa Rica. Its seven factors are family support,
community organization and support, physical exercise, medical control, hygiene
and self-care and assessment of physical condition. Aim: To assess the psychometric
properties of the scale in Chilean patients. Material and Methods: The
results of the EATDM-III scale, applied to 274 patients with Diabetes Mellitus 2
aged 59 ± 11 years (59% women), were analyzed. Reliability, item, exploratory
and confirmatory factorial analyses were carried out both in the initial and the
proposed model. Results: We propose a version of 30 items grouped in six dimensions,
improving the fit indices obtained with the original scale. The review
of item factor loadings shows that all are appropriate both in magnitude and
statistical significance, with values between 0.46 and 0.93. Internal consistency
measured by Cronbach’s alpha, was 0.85 for the total scale. Conclusions: The
adapted EATDM-III scale is reliable and can be used to assess treatment adherence
in Chilean patients.